Search Results for keywords:"pharmaceutical regulations"

Search Results: keywords:"pharmaceutical regulations"

S. 1096 — To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
💰
April 10, 2025
Status:Reported to Senate
Congress:119
Words:8,826
The bill S. 1096, also known as the "Preserve Access to Affordable Generics and Biosimilars Act," aims to prevent brand-name drug companies from paying generic drug companies to delay their cheaper drugs from entering the market. This tactic, known as "reverse payment"...
Simple Explanation
The bill wants to stop big drug companies from paying to keep cheaper, similar drugs away so people can get them sooner and pay less. If companies break the rules, they might get in trouble with the people in charge.
H. R. 7635 — To amend title III of the Social Security Act to ensure the accessibility of drugs furnished under the 340B drug discount program.
💰
March 12, 2024
Status:Introduced in House
Congress:118
Words:1,698
The bill, H.R. 7635, aims to ensure that hospitals, clinics, and health centers can access discounted drugs through the 340B drug discount program. It specifies that drug manufacturers must provide these discounts without placing any conditions on how or where the drugs are...
Simple Explanation
The bill H.R. 7635 wants to make sure hospitals and clinics can get important medicines at a discount from a special program without companies setting extra rules, helping them take care of more people. If companies break these rules, they might have to pay big fines, so everyone gets the help they need.

Showing 1 to 2 of 2 results